Press releases
Pharmacolog i Uppsala AB (publ) announces today that the interim report for the period January – September 2023 has been published.
ANNOUNCEMENT FROM THE EXTRAORDINARY GENERAL MEETING OF PHARMACOLOG I UPPSALA AB ON NOVEMBER 15, 2023
Extraordinary General Meeting in Pharmacolog i Uppsala AB, reg. no. 556723-6418, (the "Company"), took place today, Wednesday, November 15, ...
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE USA, AUSTRALIA, BELARUS, HONGKONG, ...
The shareholders of Pharmacolog i Uppsala AB, reg. no. 556723-6418 (the "Company"), are hereby invited to an extraordinary general ...
The Board of Directors of Pharmacolog has decided to implement with immediate effect a strategy with the goal of divesting ...
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, ...
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, ...
Pharmacolog is initiating a cost-saving program that will significantly reduce ongoing operating costs while streamlining the company organization to ...
Pharmacolog i Uppsala AB (publ) has chosen to appoint Liselotte Söder as interim finance manager with immediate effect when ...
Pharmacolog i Uppsala AB (publ) announces today that the interim report for the period January - June 2023 has been published.